✦ LIBER ✦

Phase II trial of didemnin-B in advanced epithelial ovarian cancer

✍ Scribed by Joanna M. Cain; P. Y. Liu; David E. Alberts; Holly H. Gallion; Leslie Laufman; Janet O'Sullivan; Geoffrey Weiss; John N. Bickers

Publisher: Springer US
Year: 1992
Tongue: English
Weight: 157 KB
Volume: 10
Category: Article
ISSN: 0167-6997
DOI: 10.1007/bf01275473

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of didemnin B in advanced

Phase II study of didemnin B in advanced colorectal cancer

✍ Dennie V. Jones; Jaffer A. Ajani; Roxann Blackburn; Karen Daugherty; Bernard Lev 📂 Article 📅 1992 🏛 Springer US 🌐 English ⚖ 222 KB

Phase II trial of Didemnin B in patients

Phase II trial of Didemnin B in patients with advanced renal cell carcinoma

✍ Robert Motzer; Howard Scher; Dean Bajorin; Cora Sternberg; George J. Bosl 📂 Article 📅 1990 🏛 Springer US 🌐 English ⚖ 115 KB

Twenty-three patients with advanced renal cell cancer were treated with Didemnin B. One partial response was achieved (5070) in 21 evaluable patients. An allergic reaction was noted in four patients including one patient with anaphylaxis. Didemnin B is not recommended in the treatment of renal cell

A phase II trial of didemnin B in myelom

A phase II trial of didemnin B in myeloma

✍ Raymond B. Weiss; Bercedis L. Peterson; Steven L. Allen; Scott M. Browning; Davi 📂 Article 📅 1994 🏛 Springer US 🌐 English ⚖ 272 KB

Phase II trial of intravenous hexamethyl

Phase II trial of intravenous hexamethylmelamine in patients with advanced ovarian cancer

✍ Mark D. Hauge; Harry J. Long; Lynn C. Hartmann; John H. Edmonson; Maurice J. Web 📂 Article 📅 1992 🏛 Springer US 🌐 English ⚖ 192 KB

Phase II clinical trial of didemnin B in

Phase II clinical trial of didemnin B in previously treated small cell lung cancer

✍ Dong M. Shin; Paul Y. Holoye; Arthur Forman; Rodger Winn; Roman Perez-Soler; Sha 📂 Article 📅 1994 🏛 Springer US 🌐 English ⚖ 521 KB

Phase II trial of vinblastine in advance

Phase II trial of vinblastine in advanced ovarian carcinoma

✍ Gregory P. Sutton; John A. Blessing; Mark D. Adelson; Parviz Hanjani 📂 Article 📅 1990 🏛 Springer US 🌐 English ⚖ 231 KB

A phase II trial of vinblastine in patients with refractory epithelial ovarian adenocarcinoma of the ovary was conducted by the Gynecologic Oncology Group (GOG) between March 9, 1988 and July 7, 1988. Vinblastine was administered in a dose of 9 mg/m2 intravenously every three weeks until disease pro